ANIKAnika Therapeutics, Inc.

ANIK Stock Price, Valuation & Chart | Anika Therapeutics, Inc.

Compare

$21.550+0.44 (+2.08%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices ANIK intrinsic value ANIK calculated fair value vs price

Overview Financials Dividends Ratios

ANIK Historical price chart

ANIK Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization288.40M

PE Ratio43.98

EPS0.49

Trading Volume77.74K

Today's High/Low21.66/20.96

Dividend Yield0.00

52 Week High/Low22.88/8.37

Shares Outstanding13.38M

ANIK Financial Statement

ANIK Analyst ratings

ANIK Analysis & performance metrics

ANIK Company profile

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain…

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on…

ANIK Management team

Name

Position

Ian W. McLeod

Vice President & Chief Accounting Officer

Ben Joseph

Vice President of Commercial & Corporate Development

Cheryl Renee Blanchard Ph.D.CEO

President, Chief Executive Officer & Director

James Chase

Senior Vice President of International Sales & Marketing

Lisa Funiciello

Vice President of Human Resources

Stephen D. GriffinCFO

Executive Vice President, Chief Financial Officer & Treasurer

David Colleran J.D.

Executive Vice President, General Counsel & Corporate Secretary

Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

Name

Position

Ian W. McLeod

Vice President & Chief Accounting Officer

Ben Joseph

Vice President of Commercial & Corporate Development

Cheryl Renee Blanchard Ph.D.CEO

President, Chief Executive Officer & Director

James Chase

Senior Vice President of International Sales & Marketing

Lisa Funiciello

Vice President of Human Resources

Stephen D. GriffinCFO

Executive Vice President, Chief Financial Officer & Treasurer

David Colleran J.D.

Executive Vice President, General Counsel & Corporate Secretary

Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

Management Team

Ian W. McLeod

Vice President & Chief Accounting Officer

Ben Joseph

Vice President of Commercial & Corporate Development

Cheryl Renee Blanchard Ph.D.CEO

President, Chief Executive Officer & Director

James Chase

Senior Vice President of International Sales & Marketing

Lisa Funiciello

Vice President of Human Resources

Stephen D. GriffinCFO

Executive Vice President, Chief Financial Officer & Treasurer

David Colleran J.D.

Executive Vice President, General Counsel & Corporate Secretary

Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

Management

Ian W. McLeod

Vice President & Chief Accounting Officer

Ben Joseph

Vice President of Commercial & Corporate Development

Cheryl Renee Blanchard Ph.D.CEO

President, Chief Executive Officer & Director

James Chase

Senior Vice President of International Sales & Marketing

Lisa Funiciello

Vice President of Human Resources

Stephen D. GriffinCFO

Executive Vice President, Chief Financial Officer & Treasurer

David Colleran J.D.

Executive Vice President, General Counsel & Corporate Secretary

Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

Total 8 executives

ANIK Frequently asked questions

What is Anika Therapeutics, Inc. (ANIK) Stock Price?

Current stock price of Anika Therapeutics, Inc. (ANIK) stock is $21.550. The stock price is +2.08% higher in the session. The intraday range can be seen from this page. Volume of Anika Therapeutics, Inc. (ANIK) stock is 77.74K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Anika Therapeutics, Inc. (ANIK) stock price going up or down today?

The stock price of Anika Therapeutics, Inc. (ANIK) can change with earnings, company news, and overall market sentiment. Anika Therapeutics, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Anika Therapeutics, Inc. stock expensive at its current price?

Whether Anika Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANIK on this page is 43.98. EPS on this page is 0.49. Compare those figures with peers and growth expectations before deciding if the current Anika Therapeutics, Inc. price is justified.

How has the stock price of Anika Therapeutics, Inc. (ANIK) performed historically?

Historical performance for Anika Therapeutics, Inc. (ANIK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANIK reacted to past earnings and market events.

Should I buy Anika Therapeutics, Inc. (ANIK) stock, at this price?

Buying Anika Therapeutics, Inc. (ANIK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.